GENERAL28 Sept 2026
Krsnaa Diagnostics to sell diagnostic equipment worth up to ₹120 crore - CNBC TV18
Krsnaa Diagnostics' board has approved selling some of its diagnostic equipment for up to ₹120 crore. The company wants a lighter, more capital-efficient way of working. These assets are freehold and are not part of the security given to lenders. Management says the deal should not hit daily operations or profits. Still, the share price fell 2.15% on the BSE. If you hold the stock, read the announcements.
Key Statutory Highlights
- Krsnaa Diagnostics' board approved the sale of identified diagnostic equipment worth up to ₹120 crore.
- The assets being sold are freehold and are not part of the security package given to lenders.
- The company said the transaction is not expected to materially affect its operations or profit and loss account.
Actionable Advice for Taxpayers / Founders:If you hold or are tracking Krsnaa Diagnostics shares, wait for the company's official filings on this sale before you buy or sell, and treat the drop in share price as market reaction rather than confirmed business loss.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: